⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
WVE News
Wave Life Sciences Ltd. Ordinary Shares
Ambulatory EHR Excellence 2026: Top Vendors Recognized for Breakthrough Innovation and Specialty User Satisfaction in Black Book 2026 Surveys
accessnewswire.com
NTST
ATHA
QRHC
PROV
WVE
MTC
WELL
MED
ORCL
SPRY
PATN
Wave Life Sciences Highlights Strategic Priorities for 2026 at the 44th Annual J.P. Morgan Healthcare Conference: Accelerating Development of WVE-007 (INHBE siRNA) for Obesity and Rapidly Advancing RNA Editing Portfolio
globenewswire.com
WVE
Wave Life Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference
globenewswire.com
WVE
Winbond Launches 8Gb DDR4 DRAM Built on Advanced 16nm Process Technology for Industrial and Embedded Applications
prnewswire.com
WVE
Wave Life Sciences Prices Upsized $350 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
globenewswire.com
WVE
Wave Life Sciences Announces Proposed $250 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
globenewswire.com
WVE
Turnarounds and 18,000% Growth
globenewswire.com
TWG
PAVS
WVE
Wave Life Sciences Announces Positive Interim Data from Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity; Single Dose Resulted in Improvement in Body Composition With Fat Loss Similar to GLP-1 at Three Months Without Muscle Loss
globenewswire.com
WVE
Wave Life Sciences to Announce Interim Data from the Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity on Monday, December 8, 2025
globenewswire.com
WVE
Wave Life Sciences Reports Third Quarter 2025 Financial Results and Provides Business Update
globenewswire.com
WVE